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Background
Pneumococcal disease kills over 1.6 million people each
year. The vast majority of its victims come from devel-
oping countries. Meningitis cases due to S. pneumoniae
have one of the highest mortality rates in pneumococcal
diseases. However there is no data on clinical and eco-
nomic burden of pneumococcal meningitis (PM) in
Malaysia. Aim of this study was to estimates the clinical
and economic burden of PM in Malaysia
Methodology
The clinical and economic burden of pneumococcal
meningitis (ICD code G00.1) was assessed using a two
years retrospective review of patient’s medical records
(2008-2009) from four public hospitals in Malaysia. The
cases of PM were identified the using ICD 10 diagnoses
codes and were assigned CBG group using MY DRG from
UNU Casemix system. Costs of PM were estimated based
on the MY DRG using step down costing methodology
from hospital cost data. The annual cost of the disease
was stratified for pediatric and adult cases.
Result
There are 2,809 PM cases annually; out of these 1,392
belongs to the pediatric age group while 1,417 were adult
cases. Cost per episode of pneumococcal meningitis was
calculated. The cost for inpatient pediatric pneumococcal
meningitis was estimated as RM 6,027 while for inpatient
adult case was estimated as RM 4,985. The cost for pedia-
tric outpatient pneumococcal meningitis visit was RM 824
while that for adult case was RM 515. Total direct cost for
pneumococcal meningitis is estimated to be RM
3,737,584, of which 52% (RM 1,785,811) were due to
pediatric cases while 48% (RM 1,951,773) were generated
by adult cases in Malaysia.
Conclusion
PM is presented a significant burden for Malaysian
population and society. The disease burden can be
reduced through vaccination.
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